Reversible Symptomatic Myocarditis Induced by All-Trans Retinoic Acid Administration during Induction Treatment of Acute Promyelocytic Leukemia: Rare Cardiac Manifestation as a Retinoic Acid Syndrome
Journal of Cardiovascular Ultrasound
; : 95-98, 2011.
Article
en En
| WPRIM
| ID: wpr-179798
Biblioteca responsable:
WPRO
ABSTRACT
Treatment by All-trans retinoic acid (ATRA) followed by anthracycline-AraC chemotherapy has improved the outcome of acute promyelocytic leukemia. ATRA is usually well tolerated, but a few major side effects can be observed. Retinoic acid syndrome (RAS) often occurs during the induction chemotherapy of acute promyelocytic leukemia. A pericardial effusion is a common cardiac manifestation but myocarditis has been rarely documented. Here we reports a very rare case of fully recovered myocarditis as a result of RAS related to ATRA administration during induction treatment of acute promyelocytic leukemia which documented by echocardiographic evidence.
Palabras clave
Texto completo:
1
Base de datos:
WPRIM
Asunto principal:
Derrame Pericárdico
/
Tretinoina
/
Leucemia Promielocítica Aguda
/
Quimioterapia de Inducción
/
Miocarditis
Tipo de estudio:
Diagnostic_studies
Idioma:
En
Revista:
Journal of Cardiovascular Ultrasound
Año:
2011
Tipo del documento:
Article